Company Overview and News

0
CANADA STOCKS-TSX futures lower as oil prices slip

2018-07-16 reuters
July 16 (Reuters) - Futures for Canada’s main stock index were lower on Monday as oil prices fell on the back of easing concerns about supply disruptions and potential production increases by countries such as Russia.
CCAOF CBL

0
117 Monthly Pay Canadian Dividend Stocks Cast 2% To 23% Yields To July 2019

2018-07-03 seekingalpha
Monthly Paying (MoPay) dividend equities make dividend payouts to shareholders twelve times a year instead once, twice, or four times.
CCAOF CJ FFN CBL NAF.UN CRLFF AD ALARF CRIUF MHIVF CHW.DB CJR.B CHW EFRTF AHOTF CNDCF GXOCF BK CHWWF CGIFF DVSPF CJREF GXO FNCSF

22
151 Monthly Paying Dividend SML Equities And 69 Funds For June

2018-06-21 seekingalpha
Here's your June 2018 Monthly-Paid (MoPay) Small-Mid-Large Cap Dividend, Yield, Upsides, and Net Gains reports. Nano-Cap MoPays are not listed.
SCA CCAOF "NHF" CJ CBL WSR CRLFF AD ALARF CRIUF ORC MHIVF OXLCO OXLCN SCM ATGFF SOT.UN CJR.B ECC AMZA ECCZ AGNC AHOTF ECCY PHK SRRTF QYLD PSEC OXLC ECCB NCV CJREF SCQ ECCA SUNS GNL NCZ NHF GNL.PRA PBB SRT.UN

0
119 Monthly Pay Canadian Dividend Stocks Show 1% To 19% Yields To June 2019

2018-06-02 seekingalpha
Monthly Paying (MoPay) dividend equities make dividend payouts to shareholders twelve times a year instead once, twice, or four times.
CCAOF EBGUF FFN OSP.PR.A CBL NAF.UN AD ALARF CRIUF BNEFF CHW.DB SOT.UN CJR.B CHW MR.UN AHOTF OSP CNDCF BK CHWWF CGIFF BNE LCS CJREF LCS.PR.A FNCSF

18
155 Monthly Pay SML Equities Show 1.85% To 17.92% Yields And 70 Funds Yield 7.16% To 19.5%

2018-05-21 seekingalpha
Here's your April 2018 Monthly-Paid (MoPay) Small-Mid-Large Cap Dividend, Yield, Upsides, and Net Gains Reports. Nano-Cap MoPays are not listed.
SCA CCAOF CBL GOOD AD ALARF ORC OXLCO OXLCN SCM GOODM RNW GOODN CJR.B ECC ECCZ AGNC AHOTF DR.DB.A ECCY GOODO GOODP TRSWF DR MFCSF PSEC OXLC ECCB SCQ CJREF ECCA GNL GNL.PRA PBB

10
PRESS DIGEST- Canada - May 16

2018-05-16 reuters
May 16 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
CCAOF KMI.PRA H CBL ACDVF KMI KMI.WS KMR HRNNF KMRFZ CVB AC

1
BRIEF-Callidus Capital Announces Acceptance Of Normal Course Issuer Bid

2018-04-16 reuters
* CALLIDUS CAPITAL CORP - UNDER TERMS OF NCIB, CALLIDUS MAY ACQUIRE UP TO 2.6 MILLION OF ITS COMMON SHARES
CCAOF CBL

1
Callidus Capital shares fall to all-time low after loss | Reuters

2018-04-03 reuters
NEW YORK/TORONTO (Reuters) - Shares of Callidus Capital Corp (CBL.TO), the Canadian lending company owned by private equity firm Catalyst Capital Group Inc, plunged to an all-time low on Tuesday after it reported a fourth-quarter and annual loss late on Monday.
CCAOF CBL NYTAB

0
Callidus shares tumble after Reuters report on Catalyst valuations

2018-03-26 reuters
TORONTO/NEW YORK (Reuters) - Shares of Canadian lender Callidus Capital Corp lost as much as 21.6 percent in two trading sessions, hitting an all-time low, after a Reuters report on Friday raised questions about the valuations that parent company Catalyst Capital Group Inc assigned to some of its portfolio companies.
CCAOF CBL

17
125 Monthly Pay Dividend SML Equities And 70 Funds Storm In March

2018-03-22 seekingalpha
Contents: 1. US/CDN Stocks @6.5%+ yield (125) 2. Stocks by price upside (30); 3. Closed-End Investment Companies, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) @6.5%+ yield (70).
FNNCF CCAOF CBL AD CRIUF ALARF BNEFF ORC SOT.UN CJR.B ECC DGS.PR.A ECCZ AGNC AHOTF ECCY DGS DVSPF ECCB BNE CJREF ECCA GNL GNL.PRA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TSX:CBL / Callidus Capital Corp on message board site Silicon Investor.

CBLI Campbell Resources (CCH.TO / CBLRF.OB)
C-Cor Electronics-CCBL SonicBlue
Cobalt Group-(CBLT) Anyone follow CBLK?
Internet Cable Corporation (ICBL) ANTC SFA TLTN CCBL MXIM CB HRC, Interesting Net Articles